IL-2 Recombinant antibody

IL-2 Uni-rAbTM Recombinant Antibody for WB, ELISA
Cat No. 83547-3-RR

产品说明书

CloneNo. 240358B1

宿主/亚型

Rabbit / IgG

种属反应性

mouse

应用

WB, ELISA

Il2, Interleukin-2, interleukin 2, Il 2, 240358B1

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inPMA(50ng/ml)+iono(500ng/ml)共6h换液+Bref A 18h EL-4 cells

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:500-1:2000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

83547-3-RR targets IL-2 in WB, ELISA applications and shows reactivity with mouse samples.

经测试应用 WB, ELISA Application Description
经测试反应性 mouse
免疫原 Fusion Protein 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 interleukin 2
别名 Il2, Interleukin-2, interleukin 2, Il 2, 240358B1
计算分子量 19 kDa
观测分子量15 kDa
GenBank蛋白编号 NM_008366
基因名称 IL-2
Gene ID (NCBI) 16183
RRIDAB_3671166
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein A purification
UNIPROT IDP04351
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

Interleukin-2 (Il2) is a protein initially identified as a T cell growth factor. Il2 is mainly produced by activated CD4+CD25- (helper) T cells, and induces the proliferation of these and others cells like CD8+ T cells, B and NK cells. For this reason, it has been used to treat immune-deficiencies like HIV, and induce immune response against tumors. Nevertheless, it has been shown that Il2 also acts as the main growth factor of CD4+CD25+ Regulatory T cells. Interleukin 2 mediates its functions in the target cell through the interleukin 2 receptor (Il2R). Il2R is a multimeric functional protein consisting of three different chains: Il2Rα, Il2Rβ and γc.

实验方案

Product Specific Protocols
WB protocol for IL-2 antibody 83547-3-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...